Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

Clinical Cancer Research

Volumn 7, Issue 4, 2001, Pages 861-867

  Khuri, F R ^a   Wu, H ^a   Lee, J J ^a   Kemp, B L ^a   Lotan, R ^a   Lippman, S M ^a   Feng, L ^a   Hong, W K ^a   Xu, X C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; DIGOXIGENIN; INTERLEUKIN 8; RETINOIC ACID RECEPTOR; RETINOID; TUMOR PROMOTER; VASCULOTROPIN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; EARLY CANCER; ENZYME INDUCTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA PROBE; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; CYCLOOXYGENASE 2; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MEMBRANE PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, RETINOIC ACID; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034901568     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cancer statistics
2. Cancer of the lung
3. Lobectomy for stage I lung cancer
4. Survival of patients surgically treated for stage I lung cancer
5. Results of surgery in non-small cell lung cancer
6. Prognosis and survival in resected lung carcinoma based on the new international staging system
7. K-ras oncogene activation as a poor prognostic marker in adenocarcinoma of the lung
8. Expression of blood-group antigen A - A favorable prognostic factor in non-small cell lung cancer
9. bcl-2 protein in non-small-cell lung carcinoma
10. Immunocytochemical markers in stage I lung cancer: Relevance to prognosis
11. Molecular pathologic substaging in 244 stage I nonsmall-cell lung cancer patients: Clinical implications
12. The role of RAR-β as a prognostic indicator in stage I non-small cell lung cancer
13. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
14. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinoma
15. Expression of cyclooxygenase-2 in human lung carcinoma
16. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinoma
17. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
18. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: Implications for lung cancer development
19. Nuclear retinoid acid receptor β in bronchial epithelium of smokers before and during chemoprevention
20. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells
21. 2 by oncogenic ras in human non-small cell lung cancer
22. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
23. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-jun/ c-fos dimerization
24. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs
25. Recent advances in chemoprevention of cancer
26. Cancer chemoprevention: Progress and promise